CHIP Clinic's goals: Research, preventive care
CHIP clinic in the works
Not all mutations are prognosticative
Cleveland Clinic researchers first to show sensitivity of IDH1/2 mutations to PARP inhibitor olaparib
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Maciejewski honored for work in bone marrow failure syndromes
Gene mutations discovered in some patients may lead to malignancy
New information poised to individualize patient care
Advertisement
Advertisement